Literature DB >> 12712025

Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial.

Blake Bulloch1, Amin Kabani, Milton Tenenbein.   

Abstract

STUDY
OBJECTIVE: We compare oral dexamethasone with placebo for the relief of pain in children with acute pharyngitis.
METHODS: We performed a prospective, randomized, double-blind, placebo-controlled trial of children aged 5 to 16 years who presented to the emergency department with acute pharyngitis. Children rated their pain on a standardized color analog scale and had a rapid streptococcal antigen detection test performed to determine group assignment. Children were randomized to dexamethasone (0.6 mg/kg, maximum dose 10 mg) or placebo. Blinded research assistants called all families daily to determine pain scores until the point of complete pain relief. The primary outcome measures were the time to clinically significant pain relief and the time to complete pain relief.
RESULTS: A total of 184 children were enrolled in the study. There were 85 children in the antigen-positive group, of whom 45 were randomized to dexamethasone and 40 to placebo. In children with group A beta-hemolytic streptococcal pharyngitis, the median time to clinically significant pain relief was 6 hours in the dexamethasone group versus 11.5 hours in the placebo group (P =.02; effect size of 5.5 hours with 95% confidence interval [CI] of 1.0 and 10.0 hours), and the time to complete pain relief was similar (36 hours for placebo versus 40 hours for dexamethasone, P =.86; effect size of 4.0 hours with 95% CI of -9.3 and 17.3 hours) in the placebo group. There were 99 children enrolled in the antigen-negative group, of whom 47 received dexamethasone and 52 received placebo. In this group, the median time to clinically significant pain relief was 13 hours in the dexamethasone group versus 9 hours in the placebo group (P =.32; effect size of 4 hours with 95% CI of -2 and 10 hours), and the time to complete pain relief was similar (48 hours for placebo versus 50 hours for dexamethasone, P =.61; effect size of 2 hours with 95% CI of -11.8 and 15.8 hours).
CONCLUSION: For all children with acute pharyngitis, oral dexamethasone does not decrease the time to onset of clinically significant pain relief or time to complete pain relief. However, in the subset of children with positive antigen detection test results, there is a statistically significant improvement in time to onset of pain relief, but it is of marginal clinical importance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712025     DOI: 10.1067/mem.2003.136

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  14 in total

1.  Response to 'Benefits of glucocorticoids in the treatment of bacterial meningitis in children: End of the controversy?'.

Authors:  James D Kellner
Journal:  Paediatr Child Health       Date:  2006-01       Impact factor: 2.253

2.  Steroids as adjuvant treatment of sore throat in acute bacterial pharyngitis.

Authors:  Simon C Schams; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

3.  Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice.

Authors:  Alexander Kiderman; John Yaphe; Joseph Bregman; Tamar Zemel; Arthur L Furst
Journal:  Br J Gen Pract       Date:  2005-03       Impact factor: 5.386

4.  Effect of topical nasal steroid spray in the treatment of non-specific recurrent / chronic pharyngitis - a trial study.

Authors:  Jyothy O Kumari; R Rajendran
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2008-10-22

Review 5.  Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review.

Authors:  Katrin Korb; Martin Scherer; Jean-François Chenot
Journal:  Ann Fam Med       Date:  2010 Jan-Feb       Impact factor: 5.166

6.  Effect of Oral Dexamethasone Without Immediate Antibiotics vs Placebo on Acute Sore Throat in Adults: A Randomized Clinical Trial.

Authors:  Gail Nicola Hayward; Alastair D Hay; Michael V Moore; Sena Jawad; Nicola Williams; Merryn Voysey; Johanna Cook; Julie Allen; Matthew Thompson; Paul Little; Rafael Perera; Jane Wolstenholme; Kim Harman; Carl Heneghan
Journal:  JAMA       Date:  2017-04-18       Impact factor: 56.272

Review 7.  Duration of symptoms of respiratory tract infections in children: systematic review.

Authors:  Matthew Thompson; Talley A Vodicka; Peter S Blair; David I Buckley; Carl Heneghan; Alastair D Hay
Journal:  BMJ       Date:  2013-12-11

8.  Efficacy of orally administered prednisolone versus partial endodontic treatment on pain reduction in emergency care of acute irreversible pulpitis of mandibular molars: study protocol for a randomized controlled trial.

Authors:  Olivia Kérourédan; Léonard Jallon; Paul Perez; Christine Germain; Jean-François Péli; Dominique Oriez; Jean-Christophe Fricain; Elise Arrivé; Raphaël Devillard
Journal:  Trials       Date:  2017-03-28       Impact factor: 2.279

Review 9.  Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials.

Authors:  Behnam Sadeghirad; Reed A C Siemieniuk; Romina Brignardello-Petersen; Davide Papola; Lyubov Lytvyn; Per Olav Vandvik; Arnaud Merglen; Gordon H Guyatt; Thomas Agoritsas
Journal:  BMJ       Date:  2017-09-20

10.  Corticosteroids as standalone or add-on treatment for sore throat.

Authors:  Simone de Cassan; Matthew J Thompson; Rafael Perera; Paul P Glasziou; Chris B Del Mar; Carl J Heneghan; Gail Hayward
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.